(Bloomberg) -- Moderna Inc. beat fourth-quarter revenue estimates as its struggling Covid vaccines business declined less than expected. The company reported sales in the period of $678 million, more ...
Moderna Inc. said its US Covid business did better than expected last year, a rare bright spot for the vaccine maker, which has struggled with the decline of people getting its shot. The number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results